Adcarfil-60 Injection 1's Substitute
by Others
by Others
by AYUR
by Others
by Others
by Others
by Others
Composition:
CARFILZOMIB-60MG
Uses:
Multiple Myeloma
Medicinal Benefits:
Carfilzomib, a proteasome inhibitor, is present in Adcarfil-60 Injection 1's. It suppresses proteasomes, preventing protein breakdown in MM (multiple myeloma) cells. When proteasome function is stopped within the MM cell, a protein build-up occurs within the MM cell, which destroys the malignant cells.
Adcarfil-60 Injection 1's contains Carfilzomib, which inhibits proteasomes and thereby prevents protein breakdown in MM (multiple myeloma) cells. When the proteasome action within the MM cell is disturbed, a protein accumulation occurs, destroying the cancerous cells.
No, it is unsafe to father a child while taking Adcarfil-60 Injection 1's. It is recommended for sexually active men to use condoms while on treatment and for at least several months after their last dose of Adcarfil-60 Injection 1's.
Based on the medical condition, Adcarfil-60 Injection 1's may be given alone or together with other medicines used to treat multiple myeloma.
Tell your healthcare professional immediately if you get any signs of an infusion-related reaction during or after the infusion. Your doctor may give other medicines, or the infusion may need to be slowed down or stopped.
Adcarfil-60 Injection 1's can cause a significant decrease in the number of blood cells and platelets. Your doctor may suggest laboratory tests before and during the treatment. Tell your healthcare provider if you develop a fever or have signs of bruising or bleeding.